Skip to main content
. Author manuscript; available in PMC: 2011 Nov 4.
Published in final edited form as: Brain Res. 2010 Sep 26;1359:178–185. doi: 10.1016/j.brainres.2010.08.093

Fig. 2. X+XO treatment increases oxidative stress and serum corticosterone levels.

Fig. 2

X+XO-treated rats had increased plasma and urinary 8-isoprostane levels (a marker of oxidative stress). X+XO treatment increased MDA levels in the hippocampus and amygdala as compared to control rats. Corticosterone levels measured by EIA (cat#500651, Cayman Chem. Co., Ann Arbor, MI) increased in X+XO treated rats as compared to control rats. *significantly different from control, p<0.05, ANOVA, N=8-12 rats.